Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PICASSO: Intraarticular Steroids, Saline or Occupational Therapy in CMC-1 Osteoarthritis
NCT06084364Phase 4Active, not recruiting
- Sponsor
- Diakonhjemmet Sykehus
- Start
- Nov 2023
- Primary completion
- Feb 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of triamcinolone acetonide in osteoarthritis (OA) (3 arms), sponsored by Diakonhjemmet Sykehus. Primary endpoint: Pain during activities in thumb base joint at 12 weeks. Started Nov 2023; status: active, not recruiting.
02
Drugs
triamcinolone acetonide
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT06084364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06084364.